ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome

ClinicalTrials.gov ID: NCT04572243

Public ClinicalTrials.gov record NCT04572243. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study With Open-Label Extension Phase of Lorcaserin as Adjunctive Treatment in Subjects With Dravet Syndrome

Study identification

NCT ID
NCT04572243
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eisai Inc.
Industry
Enrollment
22 participants

Conditions and interventions

Interventions

  • Lorcaserin Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 22, 2020
Primary completion
Aug 14, 2024
Completion
Aug 14, 2024
Last update posted
Oct 7, 2025

2020 – 2024

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
Children's of Alabama / University of Alabama at Birmingham Birmingham Alabama 35226
University of California Los Angeles (UCLA) Los Angeles California 90095
UCSD Rady's Children's Hosptial San Diego California 92123
Children's Hospital Colorado Aurora Colorado 80045
Northwest Florida Clinical Research Group Gulf Breeze Florida 32561
Joe DiMaggio Children's Hospital Hollywood Florida 33021
Miami Children's Hospital - Nicklaus Children's Hospital Miami Florida 33155
Pediatric Neurology, P.A. Winter Park Florida 32789
Rare Disease Research Center Pediatrics, LLC Atlanta Georgia 30318
Mid-Atlantic Epilepsy and Sleep Center - Bethesda Bethesda Maryland 20817
Spectrum Health/ Helen DeVos Children's Hospital Grand Rapids Michigan 49503
University of Missouri, Department of Child Health, Division of Neurology Columbia Missouri 65201
Institute of Neurology and Neurosurgery at Saint Barnabas Livingston New Jersey 07039
Northwell Health - Neuroscience Institute at Great Neck New Hyde Park New York 10075
NYU Langone Comprehensive Epilepsy Center New York New York 10016
New York Medical College New York New York 10019-1147
NorthWell Health - Lennox Hill Hospital New York New York 11021
University of Rochester Medical Center Rochester New York 14642
University of North Carolina Chapel Hill North Carolina 27599-7025
Duke University Hospital Center Durham North Carolina 27710
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224
The University of Texas Health Science Center at Houston Houston Texas 77030
Seattle Children's Hospital Seattle Washington 98105
MultiCare Institute for Research & Innovation Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04572243, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 7, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04572243 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →